Why the study?
Does nitrendipine compared to enalapril reduce blood pressure in patients with mild to moderate essential hypertension?
Does nitrendipine compared to enalapril reduce blood pressure in patients with mild to moderate essential hypertension?
Nitrendipine and enalapril are equally effective as monotherapy for mild to moderate essential hypertension, with their use limited primarily by specific side effects rather than lack of efficacy.
Answers are grounded in this paper and cite their sources.
Nitrendipine matches enalapril for BP lowering in mild-moderate hypertension; confirms equivalent monotherapy efficacy in this RCT.
In this study, we compared the effects of nitrendipine (2(1–4(1 mg daily) and enalapril (20–40 nig daily) in 44 patients with mild to moderate essential hypertension. Alter a 4-week placebo period, the patients entered a double-blind. crossover study of 16 weeks, divided by a second 4-week placebo period. Sitting and standing blood pressures (standard mercury meter) were measured every 2 weeks. Ten patients dropped out. so 34 patients were evaluable. Two patients dropped out because of surgery, one patient was withdrawn because of accelerating hypertension, and sewn patients discontinued because of side elfects (two on placebo. four on enalapril. and one on nitrendipine). Sitting blood pressures decreased from 172 ± 3/107 ± 1 to 159 ± 3/94 ± l mm llg on nitrendipine (p † 0.001) and to 157 ± 4/96 ± 2 mm Hg on enalapril (p < 0.001). The heart rate did not change. Both compounds had no significant effect on scrum lipids and on renal function. With regard to side elfects. Hushing occurred in 10 patients on nitrendipine and in 3 on enalapril (p <0.05): cough was noted in 3 patients on enalapril. When using a diastolic pressure < 95 mm llg as a response. 72% responded on nitrendipine and 64% on enalapril (n.s.). In conclusion, nitrendipine and enalapril. given as monotherapy, were equally effective antihypertensive agents in this group of patients with uncomplicated, moderate. essential hypertension. The use of either of the tested agents seems to be more limited by its specific side elfects than the lack of antihypertensive efficacy.
No takes yet. Share an insight, caveat, or question.
Verkaaik et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: